| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1700071 | 重组Fc糖基化修饰抗CD20人源化单克隆抗体注射液 | Recombinant Glycosylation-modified Anti-human-CD20 Monoclonal Antibody | Injection | Biological Products(1) | New Drug Application | 2017-08-10 | 百奥泰生物科技（广州）有限公司 | Bio-Thera Solutions Ltd | Certificate Issued | 2018-03-20 | view |